TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/15/22 18:53 | 9/13/22 | CDAK | Codiak Biosciences, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Arch Venture Fund Viii, L.P. | IL | T | P.d | 7,500 | 1.50 | 0 | 5,000 | 130 | 8,854 | I | |||||||||||||||
10/20/20 20:07 | 10/16/20 | CDAK | Codiak Biosciences, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Arch Venture Fund Viii, L.P. | IL | T | P.d | 3,525 | 15.00 | 0 | 235 | 10 | 2,504 | I | |||||||||||||||
9/22/20 11:07 | 9/18/20 | MTCR | Metacrine, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Arch Venture Fund Viii, L.P. | IL | T | P.d | 2,990 | 13.00 | 0 | 230 | 159 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |